A team of scientists and clinicians including Brian Lichty, associate professor of pathology and molecular medicine in the Michael G. DeGroote School of Medicine, and Sébastien Hotte, associate professor of oncology, is developing a treatment for prostate cancer using viruses that destroy cancer cells and boost the anti-cancer immune response, yet leave normal cells unharmed.
The team has received $5 million from the Prostate Cancer Canada and the Movember Foundation.
The funding will support research on a specific viral therapy for prostate cancer, one based on the fact that many cancer cells have weak anti-viral defense mechanisms.
New research suggests that the risks of developing type 2 diabetes for South Asians — a group long known to suffer from substantially higher rates of both diabetes and heart disease — begins immediately at birth.
The research from the South Asian Birth Cohort study (START), published online today in the International Journal of Obesity, is significant because it suggests South Asian women who minimize their risk of gestational diabetes and avoid excessive weight gain in pregnancy may help to prevent diabetes in their own children.
"South Asian pregnant women should be considered high risk for gestational diabetes and routinely screened in pregnancy," says Sonia Anand, principal investigator and a professor of medicine and epidemiology and Heart and Stroke Chair in Population Health Research at the Michael G. DeGroote School of Medicine at McMaster University.
Paul O'Byrne, chair of the Department of Medicine at the Michael G DeGroote School of Medicine, was one of 35 new fellows inducted into the Canadian Academy of Health Sciences (CAHS).
O'Byrne is internationally recognized for seminal contributions into understanding the causes and treatment of asthma, including the first studies of the central role of airway inflammation in its initiation and persistence